Factors affecting hepatitis B immunization in celiac disease

Aim: While 90-95% of the adult population responds to hepatitis-B vaccination, it is known that, this rate is lower in patients withCD. In our study, determination of response rates of vaccinated celiac patients, and the affecting factors associated with vaccineresponses were the aims of our investigation.Material and Methods: The study included 280 celiac patients who applied to the polyclinic between 2015-2019 years. Demographic,anthropometric characteristics (age, gender, onset age, disease duration, smoking, body mass index(BMI), waist-hip ratios) andsymptoms in patients were documented. Hepatitis B, C, delta serology were examined. The prevalence of chronic hepatitis andassociated risk factors were evaluated. Hepatitis-B vaccination rates and vaccine responses were determined. The risk factorsassociated with the immune response were reviewed.Results: 212 (75.7%) of the patients were female, the mean-age of the patients was 33.4±10.8 and the disease duration was 4.9±3.7years. In 14 (5%) of the patients there were chronic viral infections, 18 (6.4%) had natural immunity, 92 (32.9%) were immunized,58 (56.4%) were not encountered with viral infection. No significant correlation was found between the presence of chronic viralhepatitis and risk factors. 28 (30.4%) patients who had not vaccine response. It was observed that; the dietary incompatibility andabsence of immunological remission were significantly higher, the BMI and the waist size were significantly lower in non-responsegroup (P

PDF

___

2. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43.
3. Plot L, Amital H. Infectious associations of Celiac disease. Autoimmun Rev 2009;8:316-9.
4. Soto SI, Vázquez SR, Ulla JR, et al. Onset of celiac disease after acute hepatitis B infection. Gastroenterol Hepatol 2010;33:17-20.
5. Ahishali E, Boztas G, Akyuz F, et al. Response to hepatitis B vaccination in patients with celiac disease. Dig Dis Sci 2008;53:2156-9.
6. Nemes É, Lefler É, Szegedi L, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics 2008;121:1570-6.
7. Toy M, Önder FO, Wörmann T, et al. Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis 2011;11:337.
8. Tozun N, Ozdogan O, Cakaloglu Y, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 2015;21:1020-6.
9. Gamal S, Enan K, Hussien M, et al. Association between hepatitis B virus and celiac disease patients in Khartoum state, Sudan. Clin Microbial 2013;2:107.
10. Hweta AA, Shagleb AA, Elgadi MO, et al. Anti-Hepatitis B Antibody status in children with coeliac disease. Ibnosina J Med Biomed Sci 2018;10:83.
11. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007;46:1650-8.
12. Nau AL, Fayad L, Lazzarotto Cet al. Prevalence and clinical features of celiac disease in patients with hepatitis B virus infection in Southern Brazil. Rev Soc Bras Med Trop 2013;46:397-402.
13. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997;336:196-204.
14. Assad S, Francis A. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine 1999;18:57-67.
15. Ertem D, Gonen I, Tanidir C, et al. The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol 2010;22:787-93.
16. Ertekin V, Tosun MS, Selimoglu MA. Is there need for a new hepatitıs B vaccine schedule for children with celiac disease? Hepat Mon 2011;11:634.
17. Leonardi S, Spina M, Spicuzza L, et al. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? Vaccine 2009;27:6030-3.
18. Park SD, Markowitz J, Pettei M, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr 2007;44:431–5.
19. Martinetti M, De Silvestri A, Belloni C, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000;97:234-40.
20. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992;102:330-54.
21. Marathe PH, Gao HX, Close KL. American diabetes association standards of medical care in diabetes 2017. J Diabetes 2017;9:320-4.
22. Bardella MT, Fraquelli M, Quatrini M, et al. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology 1995;22:833-6.
23. Fine KD, Ogunji F, Saloum Y, et al. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 2001;96:138-45.
24. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol 2003;98:2289-92.
25. Zanoni G, Contreas G, Valletta E, et al. Normal or defective immune response to Hepatitis B vaccine in patients with diabetes and celiac disease: An open issue. Hum Vaccin Immunother 2015;11:58-62.
26. Filippelli M, Garozzo MT, Capizzi A, et al. Immune response to hepatitis B virus vaccine in celiac subjects at diagnosis. World J Hepatol 2016;8:1105.
27. Jouneghani AS, Chaleshtori MH, Khoshdel A, et al. Evaluation of response to hepatitis B vaccine in Iranian 6–18-year-old students. J Res Med Sci 2017;22:116.
28. Yang S, Tian G, Cui Y, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep 2016;6:27251.
29. Meriki HD, Tufon KA, Anong DN, et al. Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon. PloS One 2018;13:0200157.
30. Chathuranga L, Noordeen F, Abeykoon A. Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka. Int J Infect Dis 2013;17:1078-9. 1483